Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Daiichi Sankyo
Harvard Business School
US Department of Justice
Queensland Health

Generated: June 22, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,455,690

« Back to Dashboard

Title: L-8-oxo-7-propyl-7,8-dihydro-(9H)-guanosine
Abstract:Novel nucleosides having the structure of Formula 1 and Formula 2 are contemplated. In one aspect of the invention, controlled release dosage forms are particularly contemplated. Further, alternative routes of administration of the nucleosides having the structure of Formula 1 or Formula 2 are contemplated.
Inventor(s): Tam; Robert (Costa Mesa, CA), Averett; Devron (San Diego, CA), Wang; Guangyi (Costa Mesa, CA), Ramasamy; Kanda (Costa Mesa, CA)
Filing Date:Jun 15, 2000
Application Number:09/594,647
Claims:1. A nucleoside having the structure of Formula 1: ##STR3##

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Johnson and Johnson
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.